Aditxt (ADTX) had the highest return in September 2022 by a US stock, returning 2,081.5%.

ASSET	MONTH	% RETURN
Aditxt (ADTX)	September 2022	2,081.47%
FingerMotion (FNGR)	September 2022	262.37%
Heartbeam (BEAT)	September 2022	222.31%
Avenue Therapeutics (ATXI)	September 2022	205.45%
Akero Therapeutics (AKRO)	September 2022	183.99%
Immuneering (IMRX)	September 2022	179.69%
Alpha Star Acquisition Corporation Rights (ALSAR)	September 2022	150%
Spero Therapeutics (SPRO)	September 2022	143.9%
Sobr Safe (SOBR)	September 2022	139.29%
Prothena (PRTA)	September 2022	122.66%
Papaya Growth Opportunity Corp I Warrant (PPYAW)	September 2022	121.67%
Alpha Star Acquisition Corporation Warrants (ALSAW)	September 2022	101.01%
SRIVARU Holding Limited Warrant (SVMHW)	September 2022	100%
Enliven Therapeutics (ELVN)	September 2022	96.55%
LAVA Therapeutics (LVTX)	September 2022	86.53%
NRx Pharmaceuticals (NRXPW)	September 2022	80%
Pulse Biosciences (PLSE)	September 2022	79.69%
Forafric Global PLC Warrants (AFRIW)	September 2022	79.04%
Jowell Global (JWEL)	September 2022	78.57%
Acumen Pharmaceuticals (ABOS)	September 2022	78.47%
X4 Pharmaceuticals (XFOR)	September 2022	76.29%
Pasithea Therapeutics Corp Warrant (KTTAW)	September 2022	73.71%
Heartbeam Inc Warrant (BEATW)	September 2022	73.24%
Vertical Aerospace (EVTL)	September 2022	68.65%
Ventyx Biosciences (VTYX)	September 2022	67.43%